Mammography is an important tool for detecting breast cancer at an early stage.
When coupled with appropriate treatment, early detection can reduce breast cancer
mortality. At the request of Congress, the Food and Drug Administration (FDA) commissioned
a study to examine the current practice of mammography and breast cancer
detection, with a focus on the FDA's oversight via the Mammography Quality
Standards Act (MQSA), to identify areas in need of improvement.
Enacted in 1993, MQSA provides a general framework for ensuring national quality
standards in facilities performing screening mammography, requires that each
mammography facility be accredited and certified, and mandates that facilities will
undergo annual inspections. This book recommends strategies for achieving continued
progress in assuring mammography quality, including changes to MQSA regulation,
as well as approaches that do not fall within the purview of MQSA.
Specifically, this book provides recommendations aimed at improving mammography
interpretation; revising MQSA regulations, inspections, and enforcement;
ensuring an adequate workforce for breast cancer screening and diagnosis; and
improving breast imaging quality beyond mammography.
- Front Matter
- Executive Summary
- 1 Introduction
- 2 Improving Interpretive Performance in Mammography
- 3 MQSA Regulations, Inspections, and Enforcement
- 4 Ensuring an Adequate Workforce for Breast Cancer Screening and Diagnosis
- 5 Beyond MQSA
- Appendix A: ACR Survey Methods and Analysis
- Appendix B: Society of Breast Imaging Survey
- Appendix C: Workforce Projection Methods
- Glossary
Text
Audio
Adobe DRM
Login to your account